Medline seeks IPO 50B valuation by filing for a $5 billion offering led by Goldman Sachs and Morgan Stanley on Nasdaq.

Medline has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed public offering of its common stock.

The medical supplies maker could raise about $5 billion in a deal that could value the company at as much as $50 billion.

Medline CEO Jim Boyle received $4.3 million in total compensation for 2024 — but he wasn't the top-paid executive for the year.

Medline Inc, which is backed by Hellman & Friedman, Carlyle and Blackstone, has filed for an IPO. Headquartered in Northfield, Illinois, Medline Inc is a healthcare products distributor. The number of ...

Medline named multi-year preferred supplier deals, international expansion and takeovers as ways it will drive further growth ...

Medline makes healthcare run better. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and ...

Medline partners Connecticut Children’s to supply medical products and equipment for its 205-bed pediatric health system expansion.

MUNDELEIN, Ill.--(BUSINESS WIRE)--An estimated five to 18 percent of healthcare workers have allergies to natural rubber latex. As such, a growing number of healthcare facilities are eliminating ...

Medline said it has formed a strategic partnership with Bassett Healthcare to drive operational efficiency and savings. The company has a long-standing history with this integrated health care system ...